Jul. 17, 2025
NYK Group’s Acquisition of Healthcare Logistics Business of the Walden Group
Investment into Healthcare Logistics will contribute to Sustainable Growth and Significant Strengthening of the Logistics Business
Nippon Yusen Kabushiki Kaisha
Yusen Logistics Global Management Co., Ltd.
NYK Group’s subsidiary Yusen Logistics Global Management Co., Ltd. (“YLGM”) hereby announces that Yusen Logistics (Europe) B.V. (“YLEU”), an overseas subsidiary of Yusen Logistics Group, has committed to acquire the healthcare logistics business of the Walden Group through the acquisition of the entire share capital of Movianto International B.V. (“Movianto”)* by entering into a Put Option Agreement with Walden Group International Holding B.V. (“Walden”). Further to the completion of the consultation with the relevant works councils on this proposed transaction, which is compulsory under European law, YLEU and Walden will execute a Share Purchase Agreement based on the executed Put Option Agreement. Movianto will become a 100% subsidiary of YLEU post-acquisition subject to regulatory clearances.
1.Background of the Acquisition
The healthcare logistics business of the Walden Group includes Movianto, Eurotranspharma, Transpharma International and Walden Digital. Specializing in the healthcare industry, the business provides contract logistics, 4PL**, first mile transportation*** and distribution services from 138 locations in 12 countries throughout Europe. Walden Digital has developed innovative technological solutions including a comprehensive end-to-end supply chain visibility platform, supporting and leveraging the group's logistics and temperature-controlled transport capabilities.
Yusen Logistics Group has positioned healthcare logistics as a key growth area and has been strengthening its capabilities in medical and pharmaceutical logistics globally through its group companies****. With the Walden healthcare operations joining the Yusen Logistics Group through this acquisition, not only will the scale of the healthcare logistics business in Europe dramatically increase, but the combination of its expertise and Yusen Logistics Group’s global network will also enable the provision of higher value-added services to a broader market.
NYK has positioned logistics as a core business segment in its medium-term management plan announced in March 2023. This transaction follows our acquisition of an e-commerce logistics platform company in the UK in February 2024 and an auto parts logistics company in the Netherlands in April 2024, further enhancing our service offerings and significantly strengthening our business foundation.
This is the first global acquisition since YLGM started leading the global management of the Yusen Logistics Group*****, strengthening the Global Headquarters function, and is expected to contribute significantly to its Business Transformation.
We will continue to actively invest in the logistics business, a key growth engine of the NYK Group.
* The companies subject to this acquisition are currently held by multiple intermediate holding companies under Walden. These entities will be reorganized prior to the transaction and Movianto will become the direct parent of the operating companies
** A business model that incorporates consulting functions to optimize the customer’s entire supply chain, including the planning and execution of logistics strategies
*** The initial stage of transportation from the manufacturer, such as a pharmaceutical plant to a logistics hub
**** GSK, Yusen Logistics, and MG Real Estate Unveil the Largest Pharmaceutical Warehouse in Wallonia, Confirming Belgium’s Strategic Position in the Biopharmaceutical Sector | Yusen Logistics
Yusen Logistics France opens a new logistics site in Dunkirk | Yusen Logistics | Japan
***** NYK Takes Measures to Enhance Yusen Logistics’ Global Management | NYK Line
Commencement of Operations at Yusen Logistics Global Management | Yusen Logistics | Japan
2.Overview of Walden healthcare logistics business
Name of the legal entity | Movianto International B.V. |
Address | Oss, Netherlands |
Shareholder | Walden Group International Holding B.V. (100%) |
Description of business | Temperature controlled transportation and warehousing services specialized for pharmaceuticals |
2024 Group revenue | Approx. EUR 790 million (Approx. JPY 134 billion)* |
Number of group employees | Approx. 5,400 |
3.Purchase price
Purchase price : Approx. EUR 1.25 billion (Approx. JPY 210 billion)
NYK Group’s Medium-Term Business Investment Policy
On March 10, 2023, the NYK Group released its medium-term management plan “Sail Green, Drive Transformations 2026 — A Passion for Planetary Wellbeing.”
The NYK Group is promoting growth strategies with ESG at the core, based on the Group’s mission statement of “Bringing value to life” and a new corporate vision for 2030, which reads, “we go beyond the scope of a comprehensive global logistics enterprise to co-create value required for the future by advancing our core business and growing new ones.”
The news on this website is as of the date announced and may change without notice.